Emmaus Life Sciences, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

DISCONTINUED OPERATIONS (Tables)

DISCONTINUED OPERATIONS (Tables)

12 Months Ended

Sep. 30, 2014

Discontinued Operations and Disposal Groups [Abstract]

Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures [Table Text Block]

Revenues, income before income taxes and net loss of NTC which are included in discontinued operations are as follows:

	2014		2013
Neuro-Therapy Clinic
Revenues	$	-	$	-
Expenses		2,700		19,400
Operating Loss before taxes	$	(2,700)	$	(19,400)
Taxes		-		-
Net Loss	$	(2,700)	$	(19,400)

The assets and liabilities of NTC are as follows:

	2014		2013
ASSETS:
Assets of Discontinued Operations	$	-	$	-

LIABILITIES:
Accounts Payable	$	86,600	$	88,500
Accrued Payroll Liabilities		90,600		130,000
Note Payable (see Note 10)		-		50,000
Liabilities of Discontinued Operations	$	177,200	$	268,500

- Definition

Tabular disclosure of disposal groups, which may include the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and pretax profit or loss reported in discontinued operations, the classification and carrying value of the assets and liabilities comprising the disposal group, and the segment in which the disposal group was reported. Also may include the amount of adjustments to amounts previously reported in discontinued operations such as resolution of contingencies arising from the disposal transaction or the operations of the component prior to disposal.

+ References + Details